← Back to catalogue

Vysis

FDA UDI

Class II (US FDA UDI)

by Abbott Molecular

Identity

Trade Name
Vysis FDA UDI
Generic Name
Cancer/tumour-associated aneuploidy IVD, probe FDA UDI
Device Name
CEP 8 SpectrumOrange FDA UDI
Model / Reference
07J22-008 FDA UDI
Description
CEP 8 SpectrumOrange FDA UDI

Identifiers

Catalog Number
07J22-008 FDA UDI
Primary DI / UDI-DI
00884999027077 FDA UDI
510(k) Number
K953591 FDA UDI
FDA Product Code
OYU FDA UDI
KIR FDA UDI
GMDN Term
Cancer/tumour-associated aneuploidy IVD, probe FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.4700 FDA UDI
864.2280 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cancer/tumour-associated aneuploidy IVD, probe

Vysis by Abbott Molecular — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cancer/tumour-associated aneuploidy IVD, probe.

Cleared under the same submission

K953591 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Abbott Molecular

Sources (1)

  • FDA UDI 72aa01c1-c533-423b-889e-b86b3050503c 37 fields · synced Jun 8, 2026